GlassScriptPhysician profile
William N Upshaw
NPI 1932276425
$29,186.14
in general payments reported to CMS, 2019-2025
7 companies · $9,145 in 2025
The $9,145 reported for 2025 was more than what 95% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $14.81 · 2021: $59.95 · 2022: $135 · 2023: $293 · 2024: $19K · 2025: $9,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Travel and Lodging: $3,399 · Food and Beverage: $1,709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,560.00 |
| Travel and Lodging | $3,399.02 |
| Food and Beverage | $1,708.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $28,699.22 | 2022-2025 | Spravato |
| Neuronetics, INC. | $338.77 | 2019-2021 | |
| Indivior INC. | $51.68 | 2025 | Sublocade |
| Abbvie INC. | $42.61 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $21.22 | 2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $17.83 | 2025 | Austedo Xr |
| Allergan, INC. | $14.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Upshaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.